Inhibition of p53-p21 pathway promotes the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes

Molecular and Cellular Biochemistry

Volumn 354, Issue 1-2, 2011, Pages 21-28

  Yan, XueBo ^a   Lv, AnLin ^a   Xing, YuJie ^a   Liu, BoWu ^a   Hou, Jing ^a   Huang, Wei ^a   Li, Yao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

5 azacytidine; Bone marrow mesenchymal stem cells; Cardiomyocyte; Differentiation; PFT

Indexed keywords

AZACITIDINE; MEMBRANE ANTIGEN; PROTEIN INHIBITOR; PROTEIN P21; PROTEIN P53; PROTEIN P53 INHIBITOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FLOW CYTOMETRY; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; IMMUNOFLUORESCENCE; MALE; MESENCHYMAL STEM CELL; NONHUMAN; RAT; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD45; APOPTOSIS; AZACITIDINE; BENZOTHIAZOLES; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; MALE; MESENCHYMAL STEM CELLS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS;

EID: 79959789988     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0801-x     Document Type: Article

References (24)

1. Elizabeth GN (2003) Cardiovascular disease. N Engl J Med 349:60-72
2. Cao F, Sun DD, Li CX, Narsinh K, Zhao L, Li X, Feng XY, Zhang J, Duan YY, Wang J, Liu DJ, Wang HC (2009) Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J 30(16):1986-1994
3. Yoshimura H, Muneta T, Nimura A (2007) Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 327:449-462 (Pubitemid 46232315)
4. Kassem M, Abdallah BM (2008) Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res 331:157-163 (Pubitemid 350265499)
5. Wakitani S, Saito T, Caplan AI (1995) Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426
6. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103(5):697-705 (Pubitemid 29122423)
7. Waf1/Cip1 pathway by 5-aza-2′-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. Int J Oncol 26(4):863-871
8. Waf1/Cip1 pathway to inhibit cell proliferation. J Biol Chem 279(15):15161-15166
9. Hong H, Takahashi K, Ichisaka T (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460:1132-1136
10. Armesilla DA, Elvira G, Silva A (2009) P53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells. Experimental cell research 315:3598-3610
11. Briffa TG, Hobbs MS, Tonkin A, Sanfilippo FM, Hickling S, Ridout SC, Knuiman M (2011) Population trends of recurrent coronary heart disease event rates remain high. Circ Cardiovasc Qual Outcomes 4:107-113
12. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, BarnabéHeider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisén J (2009) Evidence for cardiomyocyte renewal in humans. Science 324(5923):98-102
13. Zeng Z, Jiang Z, Wang CS, Luo H, Huang YF, Jin XH (2010) Preoperative evaluation improves the outcome in heart transplant recipients with pulmonary hypertension-retrospective analysis of 106 cases. Transplant Proc 42(9):3708-3710
14. Li X, Yu X, Lin Q, Deng C, Shan Z, Yang M, Lin S (2007) Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol 42(2):295-303 (Pubitemid 46135597)
15. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC (2000) Marrou stramol cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. Thorac Cardiovasc Surg 120(62):999-1005
16. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, Kögler G, Wernet P (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106(15):1913-1918 (Pubitemid 35176294)
17. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F (2006) Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367(9505):113-121 (Pubitemid 43077127)
18. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H (2004) Intra-coronary autologous bone marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364(9429):141-148 (Pubitemid 38891685)
19. Erbs S, Linke A, Schächinger V, Assmus B, Thiele H, Diederich KW, Hoffmann C, Dimmeler S, Tonn T, Hambrecht R, Zeiher AM, Schuler G (2007) Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the doppler sub-study of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction (REPAIR-AMI) trial. Circulation 116(4):366-374 (Pubitemid 47196542)
20. Wang JA, Xie XJ, He H, Sun Y, Jiang J, Luo RH, Fan YQ, Dong L (2006) A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy. Chin J Cardiol 34(2):107-111
21. Levine AJ, Finlay CA, Hinds PW (2004) P53 is a tumor suppressor gene. Cell 116:67-69
22. Schuler M, Green DR (2005) Transcription, apoptosis and P53: catch-22. Trends Gen 21(3):182-187 (Pubitemid 40269857)
23. Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schönfeld P, Roessner A, Gali-Muhtasib H (2005) 5-aza-Cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp Ther 312(2):525-536 (Pubitemid 40189549)
24. Liu X, Chua CC, Gao J, Chen Z, Landy CL, Hamdy R, Chua BH (2004) Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am J Physiol Heart Circ Physiol 286:933-939